All In Biotech

Drug Trial Radar · NCT02912260

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-controlled Study of MGL-3196 in Patients With Non-alcoholic Steatohepatitis

Last checked: Nov 20, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 125 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

125

Actual

Start

Oct 18, 2016

Primary completion

Oct 25, 2017

Study completion Nov 23, 2021

Sponsor

Lead sponsor
Madrigal Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Sep 23, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on the percent change in hepatic fat fraction from baseline in participants with biopsy-proven Non-alcoholic Steatohepatitis (NASH).

Conditions

  • Non-alcoholic Steatohepatitis

Interventions

  • MGL-3196Drug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline To Week 12 In Hepatic Fat Fraction Assessed By Magnetic Resonance Imaging Proton Density Fat Fraction (MRI-PDFF)Time frame: Week 12

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Madrigal Research Site

    Dothan, Alabama

  • Madrigal Research Site

    Tucson, Arizona

  • Madrigal Research Site

    Coronado, California

  • Madrigal Research Site

    Los Angeles, California

  • Madrigal Research Site

    Rialto, California

  • Madrigal Research Site

    San Diego, California

  • Madrigal Research Site

    Ventura, California

  • Madrigal Research Site

    Englewood, Colorado

  • Madrigal Research Site

    Boca Raton, Florida

  • Madrigal Research Site

    Lakewood Rch, Florida

  • Madrigal Research Site

    Lauderdale Lakes, Florida

  • Madrigal Research Site

    Miami, Florida

  • Madrigal Research Site

    New Port Richey, Florida

  • Madrigal Research Site

    Kansas City, Kansas

  • Madrigal Research Site

    Monroe, Louisiana

  • Madrigal Research Site

    Baltimore, Maryland

  • Madrigal Research Site

    Jackson, Mississippi

  • Madrigal Research Site

    St Louis, Missouri

  • Madrigal Research Site

    Albuquerque, New Mexico

  • Madrigal Research Site

    New York, New York

  • Madrigal Research Site

    Durham, North Carolina

  • Madrigal Research Site

    Rapid City, South Dakota

  • Madrigal Research Site

    Live Oak, Texas

  • Madrigal Research Site

    San Antonio, Texas

  • Madrigal Research Site

    Charlottesville, Virginia

  • Madrigal Research Site

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.